LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cutting-Edge Medical Device Purifies and Concentrates Urine for Rapid Cancer Diagnosis

By LabMedica International staff writers
Posted on 03 Feb 2025

A groundbreaking medical device designed to purify and concentrate urine has the potential to revolutionize research and diagnosis of various health issues, including cancer.

Developed by Bee Robotics (based in Wales, UK) in collaboration with Bangor University (Gwynedd, UK), this prototype effectively processes urine to generate concentrated samples suitable for biological analysis. By collaborating with Bangor University, Bee Robotics was able to analyze and evaluate the automated procedure, resulting in more reliable test outcomes through the concentration and purification of urine samples. The automation aspect of this technology distinguishes it from traditional sample analysis methods, enabling faster processing times.


Image: The device has the potential for improving the early detection of various diseases (Photo courtesy of Bangor University)
Image: The device has the potential for improving the early detection of various diseases (Photo courtesy of Bangor University)

Complete automation minimizes the need for human involvement, marking a significant advancement in the diagnosis and research of various medical conditions. Although the research is still in its early phases, the scientific principles underlying the process have been a key focus for the team. Researchers intend to continue refining the methodology and advancing the prototype, which allows for sample concentration while minimizing inhibitors to improve the sensitivity of diagnostic tests.

Related Links:
Bangor University
Bee Robotics


Gold Member
Collection and Transport System
PurSafe PlusĀ®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Latest Clinical Chem. News

New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
03 Feb 2025  |   Clinical Chem.

Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
03 Feb 2025  |   Clinical Chem.

Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
03 Feb 2025  |   Clinical Chem.